27 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
that can be toxic, damaging to vital organs and result in multi-organ failure and even death. This is known as the cytokine storm.
About
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
when the body overproduces inflammatory effector cells and other molecules that can be toxic, damaging to vital organs and result in multi-organ
8-K/A
EX-99.1
ICU
SeaStar Medical Holding Corp
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
5:23pm
cells that can lead to damage of vital organs. It occurs when the body overproduces inflammatory effector cells and other molecules that can be toxic
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
8:32am
cells that can lead to damage of vital organs. It occurs when the body overproduces inflammatory effector cells and other molecules that can be toxic
424B3
ICU
SeaStar Medical Holding Corp
5 Mar 24
Prospectus supplement
5:08pm
inflammatory effector cells and other molecules that can be toxic, damaging to vital organs and result in multi-organ failure and even death. This is known
424B3
b9kmkpd3e kv
5 Mar 24
Prospectus supplement
5:06pm
424B3
wvcssq
5 Mar 24
Prospectus supplement
4:59pm
424B3
mpygu 6m3h
5 Mar 24
Prospectus supplement
4:56pm
8-K
EX-99.1
171h8v dbbgn35
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
8-K
EX-10.1
fgnnjcltv 2cuhyh
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am
8-K
EX-99.1
kcb6uxymd1ux
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
EX-99.1
4wldxbn alx
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
424B3
5702s vne
6 Oct 23
Prospectus supplement
1:08pm
424B3
k3ehufyk2a
6 Oct 23
Prospectus supplement
1:06pm
424B3
rbspqq2 sh2hslx
6 Oct 23
Prospectus supplement
1:04pm
424B3
t3mi1e
6 Oct 23
Prospectus supplement
12:59pm
8-K
EX-99.1
ofwxqqjmu 2cm9
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
EX-9.1
5j4d0ng2 u62ygne9w0
24 Aug 23
Regulation FD Disclosure
5:15pm
8-K
EX-99.1
9oq16u3f qzb1
14 Aug 23
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
6:46pm
424B3
dot4jp0p96g2sjyx42
23 May 23
Prospectus supplement
5:29pm